Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.53 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.53 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.48 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.48 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.48 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.48 |
| ▸ | RRM1 | P23921 | 1/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6940719 | 1.00 | SIRT6 (0.53) | SIRT6SIRT1PLA2G2CGNAI3GNAO1 | |
| SCHEMBL6939793 | 1.00 | SIRT6 (0.53) | SIRT6SIRT1PLA2G2CGNAI3GNAO1 | |
| SCHEMBL6935932 | 0.97 | SIRT6 (0.50) | SIRT6SIRT1PLA2G2CGNAI3GNAO1 | |
| SCHEMBL6940709 | 0.94 | PLA2G2C (0.48) | SIRT6SIRT1PLA2G2CGNAI3GNAO1 | |
| SCHEMBL6938815 | 0.86 | PLA2G2C (0.57) | PLA2G2CGNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL19271824 | 0.82 | PLA2G2C (0.64) | SIRT6SIRT1PLA2G2CPLA2G2A | |
| SCHEMBL11606057 | 0.82 | PLA2G2C (0.64) | SIRT6SIRT1PLA2G2CPLA2G2A | |
| SCHEMBL19271786 | 0.82 | PLA2G2C (0.64) | SIRT6SIRT1PLA2G2CPLA2G2A | |
| SCHEMBL6940595 | 0.82 | PLA2G2C (0.64) | SIRT6SIRT1PLA2G2CPLA2G2A | |
| SCHEMBL30887481 | 0.82 | PLA2G2C (0.64) | SIRT6SIRT1PLA2G2CPLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1285579-B1 | Bactericidal guanidine derivatives, dermally applicable composition, washing composition, and antibacterial fibre aggregate | AJINOMOTO KK (JP) | 2005-11-02 | — | — | EP | disclosed |
| US-20030162838-A1 | Bactericide, antiseptic, dermally applicable composition, washing composition, antibacterial fiber aggregate, method for eradicating a microorganism, and method for inhibiting the proliferation of a microorgamism | AJINOMOTO CO., INC. (JP) | 2003-08-28 | — | — | US | disclosed |
| EP-1285579-A1 | Bactericidal guanidine derivatives, dermally applicable composition, washing composition, and antibacterial fibre aggregate | Ajinomoto Co., Inc. (JP) | 2003-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162838-A1 | Bactericide, antiseptic, dermally applicable composition, washing composition, antibacterial fiber aggregate, method for eradicating a microorganism, and method for inhibiting the proliferation of a microorgamism | ARG1, ALKBH1, GANC | SIRT6 4005/4885SIRT1 3591/4885PLA2G2C 2387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.